| Product name | Per Pill | Savings | Per Pack | Order |
|---|---|---|---|---|
| 30 pills | $2.68 | $80.54 | ADD TO CART | |
| 60 pills | $2.02 | $39.87 | $161.08 $121.21 | ADD TO CART |
| 90 pills | $1.80 | $79.74 | $241.63 $161.89 | ADD TO CART |
| 120 pills | $1.69 | $119.60 | $322.16 $202.56 | ADD TO CART |
| 180 pills | $1.58 | $199.34 | $483.25 $283.91 | ADD TO CART |
| 270 pills | $1.50 | $318.94 | $724.87 $405.93 | ADD TO CART |
| Product name | Per Pill | Savings | Per Pack | Order |
|---|---|---|---|---|
| 30 pills | $1.89 | $56.84 | ADD TO CART | |
| 60 pills | $1.52 | $22.38 | $113.67 $91.29 | ADD TO CART |
| 90 pills | $1.40 | $44.76 | $170.51 $125.75 | ADD TO CART |
| 120 pills | $1.34 | $67.14 | $227.35 $160.21 | ADD TO CART |
| 180 pills | $1.27 | $111.90 | $341.02 $229.12 | ADD TO CART |
| 270 pills | $1.23 | $179.03 | $511.52 $332.49 | ADD TO CART |
| Product name | Per Pill | Savings | Per Pack | Order |
|---|---|---|---|---|
| 30 pills | $1.11 | $33.34 | ADD TO CART | |
| 60 pills | $0.93 | $10.91 | $66.69 $55.78 | ADD TO CART |
| 90 pills | $0.87 | $21.83 | $100.04 $78.21 | ADD TO CART |
| 120 pills | $0.84 | $32.74 | $133.38 $100.64 | ADD TO CART |
| 180 pills | $0.81 | $54.56 | $200.06 $145.50 | ADD TO CART |
| 270 pills | $0.79 | $87.30 | $300.10 $212.80 | ADD TO CART |
| 360 pills | $0.78 | $120.04 | $400.14 $280.10 | ADD TO CART |
Singulair: Understanding Uses, Side Effects and Where to Buy Online
Singulair (montelukast) is a prescription medication used to treat asthma, exercise-induced bronchospasm, and allergies. It works by blocking a group of natural substances called leukotrienes that can exacerbate asthma and allergy symptoms. The medication is available in various forms including tablets, chewable tablets, and granules.
This article will explore the different uses of Singulair, its potential side effects, and how to buy it safely online.
What is Singulair used for? Singulair is used for the following purposes:
The medication is often prescribed in combination with other asthma drugs. It can be used in adults and children as young as 6 months old.
How does Singulair work? Singulair is a leukotriene receptor antagonist. Leukotrienes are inflammatory chemicals produced by white blood cells. When released in the lungs, they can cause inflammation, mucus buildup, and constriction of the airway muscles, making breathing difficult. By blocking the action of leukotrienes, Singulair helps to relax the airway muscles, reduce inflammation, and relieve symptoms like wheezing, coughing, and shortness of breath.
Side effects of Singulair Like other medications, Singulair can cause side effects. Common side effects include:
• Stomach pain • Headache • Sore throat • Flu • Runny nose • Fever • Unusual dreams • Trouble sleeping • Nausea • Vomiting • Diarrhea • Increased bruising • Infections
In rare cases, Singulair may cause more serious side effects like: • Agitation • Aggressive behavior • Hallucinations • Sleep disturbances • Suicidal thoughts • Tremors • Eosinophilic granulomatosis with polyangiitis (a rare condition that causes inflammation in various parts of the body)
If you experience any side effects while taking Singulair, contact your doctor. In particular, report any signs of mental health changes.
How to take Singulair Singulair is usually taken orally once daily in the evening. It can be taken with or without food. The typical dose is:
Doses may be adjusted by your doctor based on your response to treatment. Do not change your dosage or stop taking the drug without consulting with your healthcare provider.
Buying Singulair online safely If you've been prescribed Singulair, you can buy it from a pharmacy or online. When purchasing online, ensure you only use reputable and licensed pharmacies. Look for websites displaying the VIPPS seal or licensed by the National Association of Boards of Pharmacy (NABP). Avoid unverified websites selling illegal versions of Singulair.
In the US, you'll need a valid prescription from a doctor to purchase Singulair from an online pharmacy. Do not share your prescription with anyone else.
Discounts may be available from online pharmacies, especially if you buy in bulk. Verify any discounts with the pharmacy and ensure you use a secure website when making payments.
In summary, Singulair is a commonly used medication for asthma, exercise-induced bronchospasm, and allergies. While generally safe, it can cause side effects ranging from mild to serious. If prescribed, take it as directed by your doctor. Buying online can be a convenient option but only use reputable pharmacies. Consult with your doctor if you have any questions or concerns about Singulair.
Leukotrienes and Their Role in Asthma and Allergic Rhinitis
Introduction Leukotrienes are a type of eicosanoid that play a crucial role in inflammation and allergic reactions. They are produced by various cells, including macrophages, eosinophils, and mast cells, in response to antigen exposure or other stimuli. Leukotrienes have been implicated in the development and exacerbation of respiratory disorders such as asthma and allergic rhinitis. In this article, we will explore the role of leukotrienes in these conditions and discuss their potential as therapeutic targets.
The Leukotriene Pathway Leukotrienes are derived from arachidonic acid, a polyunsaturated fatty acid found in cell membranes. The synthesis of leukotrienes involves a series of enzymatic reactions, which involve the conversion of arachidonic acid to the unstable intermediate leukotriene A4 (LTA4) by the enzyme 5-lipoxygenase (5-LO). LTA4 can then be converted to either LTB4 or LTC4 by the enzymes LTA4 hydrolase and LTC4 synthase, respectively.
LTB4 is a potent chemoattractant for neutrophils, monocytes, and macrophages, promoting inflammation and tissue damage. In contrast, LTC4, LTD4, and LTE4 are collectively known as cysteinyl leukotrienes (cysLTs), which are involved in smooth muscle contraction, increased vascular permeability, and mucus secretion. The cysLTs are the primary mediators of allergic asthma and rhinitis.
Role of Leukotrienes in Asthma Asthma is a complex inflammatory disorder characterized by airway obstruction, hyperresponsiveness, and remodeling. Leukotrienes play a pivotal role in the pathogenesis of asthma, as they contribute to the development of its hallmark features.
Airway obstruction is a hallmark of asthma, and leukotrienes are one of the primary mediators responsible for this. CysLTs, such as LTC4, LTD4, and LTE4, cause smooth muscle contraction, leading to bronchospasm and airway narrowing. This constriction of the airways restricts airflow and causes symptoms like wheezing, coughing, and shortness of breath.
In addition to their contractile effects, cysLTs also promote mucus secretion in the airways. Mucus accumulation further narrows the airways, exacerbating airflow obstruction. The excess mucus production is thought to be mediated by the activation of mucin genes in airway epithelial cells and submucosal glands.
Leukotrienes also contribute to airway hyperresponsiveness, another key feature of asthma. Airway hyperresponsiveness refers to an excessive constrictive response of the airways to various stimuli. CysLTs can enhance airway hyperresponsiveness by activating sensory nerve endings, leading to reflex bronchospasm and increased cholinergic tone.
Furthermore, leukotrienes play a role in airway remodeling, a process that leads to permanent structural changes in the airways of asthmatic patients. LTB4, in particular, has been implicated in promoting fibroblast proliferation and collagen deposition, contributing to the thickening of the basement membrane and airway wall remodeling.
Role of Leukotrienes in Allergic Rhinitis Allergic rhinitis is a common inflammatory disorder of the nasal mucosa, characterized by symptoms such as nasal congestion, sneezing, itching, and rhinorrhea. Leukotrienes are also involved in the pathogenesis of allergic rhinitis, particularly in the late-phase allergic response.
During the late-phase response, which occurs hours after allergen exposure, a influx of inflammatory cells, including eosinophils, neutrophils, and lymphocytes, is observed in the nasal mucosa. These cells are attracted by the chemoattractant properties of LTB4. The accumulation of these cells leads to the release of various mediators, including cysLTs, which further exacerbate the inflammatory response.
CysLTs play a crucial role in the vasodilation and increased vascular permeability observed in allergic rhinitis. They cause the contraction of nasal smooth muscle, leading to nasal congestion and obstruction. Additionally, cysLTs promote mucus secretion from nasal mucosal glands, contributing to the characteristic nasal discharge associated with the condition.
Leukotriene Modifiers as Therapeutic Agents Given the significant role of leukotrienes in asthma and allergic rhinitis, targeting the leukotriene pathway has emerged as a promising therapeutic approach for these conditions. Leukotriene modifiers, which include leukotriene receptor antagonists (LRAs) and 5-LO inhibitors, have been developed to counteract the effects of leukotrienes.
LRAs, such as montelukast and zafirlukast, are orally active drugs that selectively block the action of cysLTs on their receptors. They have been shown to be effective in improving lung function, reducing symptoms, and decreasing the need for rescue medication in mild-to-moderate asthma. LRAs are also used in the treatment of allergic rhinitis, where they have demonstrated efficacy in alleviating nasal symptoms and improving quality of life.
5-LO inhibitors, such as zileuton, are another class of leukotriene modifiers that act by inhibiting the initial step of leukotriene synthesis, thereby reducing the production of both LTB4 and cysLTs. These drugs have been found to be effective in the treatment of asthma, particularly in patients with aspirin-intolerant asthma.
Conclusion Leukotrienes play a pivotal role in the pathogenesis of asthma and allergic rhinitis, contributing to airway obstruction, hyperresponsiveness, remodeling, and the characteristic symptoms of these conditions. Understanding the leukotriene pathway and its interplay with other inflammatory mediators is crucial for the development of effective treatment strategies. Leukotriene modifiers, specifically LRAs and 5-LO inhibitors, have emerged as valuable therapeutic options for the management of mild-to-moderate asthma and allergic rhinitis. Further research into the role of leukotrienes and the development of more targeted therapies may lead to improved treatment outcomes for patients with these debilitating respiratory disorders.
FAQs
What are leukotrienes? Leukotrienes are a type of eicosanoid that play a crucial role in inflammation and allergic reactions. They are produced by various cells, including macrophages, eosinophils, and mast cells, in response to antigen exposure or other stimuli.
What are the main effects of leukotrienes in asthma? Leukotrienes contribute to airway obstruction, hyperresponsiveness, and remodeling in asthma. They cause smooth muscle contraction, mucus secretion, and attract inflammatory cells, leading to characteristic symptoms such as wheezing, coughing, and shortness of breath.
How do leukotrienes affect allergic rhinitis? Leukotrienes are involved in the late-phase allergic response in allergic rhinitis, attracting inflammatory cells and promoting vasodilation, increased vascular permeability, and mucus secretion, leading to nasal congestion, sneezing, itching, and rhinorrhea.
What are leukotriene modifiers? Leukotriene modifiers are a class of drugs that target the leukotriene pathway to counteract the effects of leukotrienes. They include leukotriene receptor antagonists (LRAs) and 5-LO inhibitors.
What are the advantages of using leukotriene modifiers? Leukotriene modifiers have been shown to be effective in improving lung function, reducing symptoms, and decreasing the need for rescue medication in mild-to-moderate asthma. They are also used in the treatment of allergic rhinitis, where they have demonstrated efficacy in alleviating nasal symptoms and improving quality of life.
Tables Table 1: Metabolism of Leukotriene A4 (LTA4)
| Enzyme | Leukotriene Product | Effects |
|---|---|---|
| LTA4 Hydrolase | LTB4 | Chemoattractant for neutrophils and macrophages |
| LTC4 Synthase | LTC4 | Smooth muscle contraction, increased vascular permeability, and mucus secretion |
| γ-Glutamyltranspeptidase | LTD4 | Smooth muscle contraction and increased vascular permeability |
| Dipeptidase | LTE4 | Smooth muscle contraction and increased vascular permeability |
Table 2: Leukotriene Modifiers Used in Asthma and Allergic Rhinitis
| Drug | Class | Mechanism of Action |
|---|---|---|
| Montelukast | Leukotriene receptor antagonist (LRA) | Selectively blocks the action of cysLTs on their receptors |
| Zafirlukast | LRA | Selectively blocks the action of cysLTs on their receptors |
| Zileuton | 5-LO inhibitor | Inhibits the initial step of leukotriene synthesis |
Lists List 1: Key Features of Asthma • Airway obstruction: Narrowing of the airways, leading to respiratory symptoms • Airway hyperresponsiveness: Excessive constrictive response of the airways to various stimuli • Airway remodeling: Permanent structural changes in the airways, leading to a loss of lung function
List 2: Symptoms of Allergic Rhinitis • Nasal congestion and obstruction • Sneezing • Nasal itching • Rhinorrhea (runny nose) • Postnasal drip • Sinus pressure and facial pain • Loss of smell • Headaches